Comparison of Hospitalization Incidence in Influenza Outpatients Treated With Baloxavir Marboxil or Neuraminidase Inhibitors: A Health Insurance Claims Database Study

BACKGROUND: Baloxavir marboxil (baloxavir) is a single-dose, oral antiinfluenza drug with a novel mechanism of action. We compared the incidence of hospitalization in patients treated with baloxavir vs neuraminidase inhibitors. METHODS: In this retrospective, observational, cohort study, we used rea...

Descripción completa

Detalles Bibliográficos
Autores principales: Komeda, Takuji, Takazono, Takahiro, Hosogaya, Naoki, Miyazaki, Taiga, Ogura, Eriko, Iwata, Shinpei, Miyauchi, Hideyuki, Honda, Keiichi, Fujiwara, Masakazu, Ajisawa, Yoshikazu, Watanabe, Hideaki, Kitanishi, Yoshitake, Hara, Kanae, Mukae, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Online Only Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423480/
https://www.ncbi.nlm.nih.gov/pubmed/33354728
http://dx.doi.org/10.1093/cid/ciaa1870

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423480/
https://www.ncbi.nlm.nih.gov/pubmed/33354728
http://dx.doi.org/10.1093/cid/ciaa1870

Ejemplares similares